Nu Skin Enterprises, Inc.
Nu Skin Enterprises, Inc.（NUS）股东结构
基于 13F 申报与流通股数据，展示机构、内部人与公众持股结构；下方为前十大机构、机构动向与内部人交易。
SEC 13F · FMP · NUS · 截至 2025年3月31日
股东结构概览
197
机构持有人数
▼ 7 vs Q4
$263.71M
机构持仓总市值
▲ $4.25M vs Q4
48.55M
总流通股
freeFloat 97.12%
36.33M
13F 申报持股数
▼ 1.35M vs Q4
机构持仓% = 13F 持股数 ÷ 总流通股。内部人% = 100 − 自由流通率。散户% = 自由流通率 − 机构%。数据来源：FMP /symbol-positions-summary + /shares-float + SEC EDGAR。
前10大机构持仓
NUS 最大股东 · 机构持仓
Q1 2025 · SEC 13F
显示前 10 家
| 机构 | 持股数 | 占比 | 权重 | 市值 | 申报日 | 变动 |
|---|---|---|---|---|---|---|
BLACKROCK, INC. wholesale-drugs, proprietaries & druggists' sundries | 4.53M | 9.11% | 9.11% | $32.90B | May 2, 2025 | ▲ 30.6K |
VANGUARD GROUP INC wholesale-drugs, proprietaries & druggists' sundries | 4.13M | 8.31% | 8.31% | $30.01B | May 9, 2025 | ▲ 193.0K |
D. E. SHAW & CO., INC. wholesale-drugs, proprietaries & druggists' sundries | 2.38M | 4.79% | 4.79% | $17.30B | May 15, 2025 | ▲ 131.9K |
RENAISSANCE TECHNOLOGIES LLC wholesale-drugs, proprietaries & druggists' sundries | 1.83M | 3.68% | 3.68% | $13.31B | May 14, 2025 | ▲ 153.8K |
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. wholesale-drugs, proprietaries & druggists' sundries | 1.39M | 2.80% | 2.80% | $10.12B | May 7, 2025 | ▲ 820.0K |
GOLDMAN SACHS GROUP INC wholesale-drugs, proprietaries & druggists' sundries | 1.32M | 2.65% | 2.65% | $9.58B | Jun 27, 2025 | ▲ 88.1K |
MORGAN STANLEY wholesale-drugs, proprietaries & druggists' sundries | 1.27M | 2.55% | 2.55% | $9.23B | May 15, 2025 | ▲ 36.8K |
GEODE CAPITAL MANAGEMENT, LLC wholesale-drugs, proprietaries & druggists' sundries | 1.15M | 2.32% | 2.32% | $8.38B | May 13, 2025 | ▲ 29.0K |
STATE STREET CORP wholesale-drugs, proprietaries & druggists' sundries | 1.06M | 2.13% | 2.13% | $7.69B | May 15, 2025 | ▼ 59.0K |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC wholesale-drugs, proprietaries & druggists' sundries | 1.05M | 2.11% | 2.11% | $7.64B | Sep 15, 2025 | ▲ 336.8K |
数据来源：SEC 13F 申报文件。变动标识：isNew / isSoldOut / changeInSharesNumber。
机构仓位变动
Q1 2025 对比上季度
Q1 2025
26
增持
+3.82M 股3
新建仓
首次建仓21
减持
−2.71M 股0
清仓
完全退出净股数变化（前50家）
+1.11M
+3.82M / −2.71M
净新增持仓人
+8
新建 3 个 / 退出 0 个
基于前50家最大机构持仓统计，全市场实际数量可能不同。
内幕交易买卖情绪
NUS 内幕交易记录
数据来源：SEC Form 4
近期内部人员以卖出为主。 卖出可能源于预定的 10b5-1 计划，不代表负面展望。
0
买入笔数
1
卖出笔数
0.00
买卖比
$0M
卖出总金额
最近内幕交易记录
最近10条 · 仅普通股
| 姓名 · 职位 | 日期 | 类型 | 股数 | 价格 | 金额 | 交易后持股 | 申报 |
|---|---|---|---|---|---|---|---|
Nathanson Laura director | May 11, 2026 | Sale | 2,676 | $6.73 | $18.0K | 30.5K | Form 4 ↗ |
WOODBURY EDWINA D director | Mar 11, 2026 | Award | 14 | $7.31 | $102.34 | 43.0K | Form 4 ↗ |
Keisel Justin S EVP, President of Global Sales | Mar 6, 2026 | Award | 47,059 | — | — | 160.2K | Form 4 ↗ |
Hatchett Steven Keith Chief Product Officer | Mar 6, 2026 | Award | 77,941 | — | — | 260.8K | Form 4 ↗ |
Clark Chayce David EVP, COO and CLO | Mar 6, 2026 | Award | 138,971 | — | — | 390.7K | Form 4 ↗ |
Thomas James D Chief Financial Officer | Mar 6, 2026 | Award | 114,706 | — | — | 267.1K | Form 4 ↗ |
NAPIERSKI RYAN S President and CEO | Mar 6, 2026 | Award | 282,353 | — | — | 1.00M | Form 4 ↗ |
Keisel Justin S EVP, President of Global Sales | Feb 26, 2026 | Tax Withhold | 13,687 | $8.63 | $118.1K | 113.1K | Form 4 ↗ |
Hatchett Steven Keith Chief Product Officer | Feb 26, 2026 | Tax Withhold | 26,001 | $8.63 | $224.4K | 182.9K | Form 4 ↗ |
Clark Chayce David EVP and General Counsel | Feb 26, 2026 | Tax Withhold | 45,502 | $8.63 | $392.7K | 251.8K | Form 4 ↗ |
数据来源：SEC Form 4。买卖方向：acquisitionOrDisposition A=买入，D=卖出。已排除 RSU 归属（M-Exempt）。
关于机构与内部人持股结构
Nu Skin Enterprises, Inc.（NUS）主要由机构投资者持有，机构持股比例约为 74.8%。公司内部人员持股约 2.88%，散户及公众持股约占剩余的 22.30%。
Nu Skin Enterprises, Inc. 最大机构股东为 BLACKROCK, INC.，截至 March 31, 2025 持有约 4.53 million 股，占总流通股的 9.11%。
目前共有 197 家机构持有 NUS 股票，合计持仓市值约 $263,705,345，数据来源为最新 SEC 13F 申报。
常见问题
NUS ownershipNu Skin Enterprises, Inc.（NUS）主要由机构投资者持有，机构持股约 74.8%。最大股东为 BLACKROCK, INC.，持股比例 9.11%。内部人员持股约 2.88%。数据来源 SEC Form 13F，截至 March 31, 2025。